Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice
作者： Thor Petersen , Fraser Moore , Tomas Kalincik , Vilija Jokubaitis , Maria Trojano
关键词:
摘要: Background:Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient highest risk early second attack and could benefit the most from disease...
core.ac.uk
sagepub.com
sci-hub.se 参考文章(30)
Olga Ciccarelli, Ahmed T Toosy, Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study Multiple Sclerosis Journal. ,vol. 21, pp. 1013- 1024 ,(2015) , 10.1177/1352458514568827
Jacqueline F. Marcus, Emmanuelle L. Waubant, Updates on Clinically Isolated Syndrome and Diagnostic Criteria for Multiple Sclerosis The Neurohospitalist. ,vol. 3, pp. 65- 80 ,(2013) , 10.1177/1941874412457183
M. W. Kattan, Postoperative nomogram for 12-year sarcoma-specific death Journal of Clinical Oncology. ,vol. 20, pp. 791- 796 ,(2002) , 10.1200/JCO.20.3.791
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, R. Pelayo, M. Comabella, J. Sastre-Garriga, X. Montalban, Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology. ,vol. 67, pp. 968- 972 ,(2006) , 10.1212/01.WNL.0000237354.10144.EC
Roberto D’Alessandro, Luca Vignatelli, Alessandra Lugaresi, Elisa Baldin, Franco Granella, Maria Rosaria Tola, Susanna Malagù, Luisa Motti, Walter Neri, Massimo Galeotti, Mario Santangelo, Laila Fiorani, Enrico Montanari, Cinzia Scandellari, Maria Donata Benedetti, Maurizio Leone, Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study Journal of Neurology. ,vol. 260, pp. 1583- 1593 ,(2013) , 10.1007/S00415-013-6838-X
Roy W. Beck, Danielle L. Chandler, Stephen R. Cole, Jack H. Simon, Lawrence D. Jacobs, R. Philip Kinkel, John B. Selhorst, John W. Rose, Joanna A. Cooper, George Rice, Thomas J. Murray, Alfred W. Sandrock, Interferon β-1a for early multiple sclerosis: CHAMPS trial subgroup analyses Annals of Neurology. ,vol. 51, pp. 481- 490 ,(2002) , 10.1002/ANA.10148
Jay M Margolis, Robert Fowler, Barbara H Johnson, Cheryl A Kassed, Kristijan Kahler, Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study BMC Neurology. ,vol. 11, pp. 122- 122 ,(2011) , 10.1186/1471-2377-11-122
L Novakova, B Skoog, B Runmarker, S Ekholm, S Winblad, V Lisovskaja, O Andersen, Clinically isolated syndromes with no further disease activity suggestive of multiple sclerosis at the age of population life expectancy Multiple Sclerosis Journal. ,vol. 20, pp. 496- 500 ,(2014) , 10.1177/1352458513496345
Mar Tintore, Àlex Rovira, Jordi Río, Susana Otero-Romero, Georgina Arrambide, Carmen Tur, Manuel Comabella, Carlos Nos, María Jesús Arévalo, Laura Negrotto, Ingrid Galán, Angela Vidal-Jordana, Joaquin Castilló, Filipe Palavra, Eva Simon, Raquel Mitjana, Cristina Auger, Jaume Sastre-Garriga, Xavier Montalban, Defining high, medium and low impact prognostic factors for developing multiple sclerosis Brain. ,vol. 138, pp. 1863- 1874 ,(2015) , 10.1093/BRAIN/AWV105
M. Tintore, A. Rovira, J. Rio, C. Tur, R. Pelayo, C. Nos, N. Tellez, H. Perkal, M. Comabella, J. Sastre-Garriga, X. Montalban, Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis Neurology. ,vol. 70, pp. 1079- 1083 ,(2008) , 10.1212/01.WNL.0000280576.73609.C6